French recommendations for the prevention of 'emerging extensively drug-resistant bacteria' (eXDR) cross-transmission

Journal of Hospital Infection

Volumn 90, Issue 3, 2015, Pages 186-195

  Lepelletier, D ^a,b   Berthelot, P ^c   Lucet, J C ^d   Fournier, S ^e,h   Jarlier, V ^e,f   Grandbastien, B ^g   Astagneau, P ^h   Baud, O ^h   Blanckaert, K ^h   Bonnet, R ^h   Bouscarra, J ⁱ   Coignard, B ^h   Ducron, C ^h   Gagnaire, J ^h   Lassere C ^h   Le Coustumier, A ^h   Mallaval, F O ^h   Nicolas Chanoine, M H ^h   Rabaud, C ^h   Souweine, B ^h   Van der Mee, N ^h   Vaux , S ^h   more..

^a NANTES UNIVERSITY HOSPITAL   (France)

^b UNIVERSITÉ DE NANTES   (France)

^c UNIVERSITY HOSPITAL OF SAINT ETIENNE   (France)

^d BICHAT HOSPITAL   (France)

^e ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^f PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^g LILLE UNIVERSITY HOSPITAL   (France)

^h NONE   (France)

ⁱ NONE   (France)

Author keywords

Carbapenemase producing Enterobacteriaceae (CPE); Extensively drug resistant bacteria (XDR); Multidrug resistant bacteria (MDR); Vancomycin resistant enterococci (VRE)

Indexed keywords

BACTERIAL COLONIZATION; BACTERIAL INFECTION; BACTERIAL TRANSMISSION; BACTERIUM; BACTERIUM CARRIER; BACTERIUM DETECTION; CARBAPENEMASE PRODUCING ENTEROBACTERIACEAE; EMERGING EXTENSIVELY DRUG RESISTANT BACTERIA; FRANCE; HEALTH CARE PLANNING; HOSPITAL ADMISSION; HOSPITALIZATION; HUMAN; INFECTION RISK; MULTIDRUG RESISTANT BACTERIA; NONHUMAN; PATIENT CARE; PRACTICE GUIDELINE; REVIEW; RISK ASSESSMENT; VANCOMYCIN RESISTANT ENTEROCOCCUS; CROSS INFECTION; DRUG EFFECTS; INFECTION CONTROL; MICROBIOLOGY; MULTIDRUG RESISTANCE; ORGANIZATION AND MANAGEMENT; PROCEDURES; STANDARDS;

CROSS INFECTION; DRUG RESISTANCE, MULTIPLE, BACTERIAL; FRANCE; GUIDELINES AS TOPIC; HUMANS; INFECTION CONTROL;

EID: 84930570709     PISSN: 01956701     EISSN: 15322939     Source Type: Journal    
DOI: 10.1016/j.jhin.2015.04.002     Document Type: Review

References (88)

1. Carlet J., Collignon P., Goldmann D., et al. Society's failure to protect a precious resource: antibiotics. Lancet 2011, 378:369-371.
2. Huttner A., Harbarth S., Carlet J., et al. Antimicrobial resistance: a global view from the 2013 World Healthcare-Associated Infections Forum. Antimicrob Resist Infect Control 2013, 2:31.
3. Ministère de la santé. Plan national d'alerte sur les antibiotiques 2011-2016. Available at: [accessed April 2015]. http://www.sante.gouv.fr/plan-national-d-alerte-sur-les-antibiotiques-2011-2016.html.
4. European Commission. Plan d'action pour combattre les menaces croissantes de la résistance aux antimicrobiens. Available at: [accessed April 2015]. http://www.infectiologie.com/site/antibiotiques.php.
5. Ministère de l'agriculture Plan national de réduction des risques d'antibiorésistance en médecine vétérinaire 2011, 32 p. Paris, Available at:, [accessed April 2015]. http://agriculture.gouv.fr/.
6. French Agency for Drug Security (ANSM) Dix ans d'évolution des consommations d'antibiotiques en France June 2012, 25 p. Paris, Available at:, [accessed April 2015]. http://ansm.sante.fr/Dossiers-thematiques/Antibiotiques/Bien-utiliser-les-antibiotiques.
7. Réseau d'alerte, d'investigation et de surveillance des infections nosocomiales (Raisin) Surveillance de la consommation des antibiotiques - Réseau ATB-Raisin - Résultats 2010 2011, 67 p. Institut de veille sanitaire, Saint-Maurice, Available at:, [accessed April 2015]. http://www.invs.sante.fr/Publications-et-outils/Rapports-et-syntheses/Maladies-infectieuses/2012/Surveillance-de-la-consommation-des-antibiotiques-Reseau-ATB-Raisin-Resultats-2010.
8. Cooper B.S., Stone S.P., Kibbler C.C., et al. Isolation measures in the hospital management of methicillin resistant Staphylococcus aureus (MRSA): systematic review of the literature. BMJ 2004, 329:533-540.
9. Carbonne A., Arnaud I., Maugat S., et al. National multidrug-resistant bacteria (MDRB) surveillance in France through the RAISIN network: a 9 year experience. JAntimicrob Chemother 2013, 68:954-959. MDRB Surveillance National Steering Group (BMR-Raisin).
10. Jarlier V., Trystram D., Brun-Buisson C., et al. Collégiale de Bactériologie-Virologie-Hygiène des Hôpitaux Universitaires de l'Ile de France. Curbing methicillin-resistant Staphylococcus aureus in 38 French hospitals through a 15-year institutional control program. Arch Intern Med 2010, 170:552-559.
11. Gagliotti C., Balode A., Baquero F., et al. EARS-Net Participants (Disease Specific Contact Points for AMR). Escherichia coli and Staphylococcus aureus: bad news and good news from the European Antimicrobial Resistance Surveillance Network (EARS-Net, formerly EARSS), 2002 to 2009. Euro Surveill 2011, 16. pii:19819.
12. High Committee of French Public Health.Commission spécialisée «Sécurité des patients» (CsSP) Maîtrise de la diffusion des bactéries commensales multi-résistantes aux antibiotiques importées en France lors de la prise en charge de patients rapatriés de l'étranger May 2010, Available at:, [accessed April 2015]. http://www.hcsp.fr/Explore.cgi/avisrapportsdomaine?clefr=201.
13. Kumarasamy K.K., Toleman M.A., Walsh T.R., et al. Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological study. Lancet Infect Dis 2010, 10:597-602.
14. Vaux S., Carbonne A., Thiolet J.M., Jarlier V., Coignard B. Emergence of carbapenemase-producing Enterobacteriaceae in France, 2004 to 2011. Euro Surveill 2011, 16. RAISIN and Expert Laboratories Groups, pii: 19880.
15. Fournier S., Monteil C., Lepainteur M., Richard C., Brun-Buisson C., Jarlier V. Long-term control of carbapenemase-producing Enterobacteriaceae at the scale of a large French multihospital institution: a nine-year experience, France, 2004 to 2012. Euro Surveill 2014, 19. Ap-Hp Outbreaks Control Group C, pii: 20802.
16. Lepelletier D., Andremont A., Grandbastien B. Risk of highly resistant bacteria importation from repatriates and travelers hospitalized in foreign countries: about the French recommendations to limit their spread. JTravel Med 2011, 18:344-351.
17. Fournier S., Brun-Buisson C., Jarlier V. Twenty years of antimicrobial resistance control program in a regional multi hospital institution, with focus on emerging bacteria (VRE and CPE). Antimicrob Resist Infect Control 2012, 1:9.
18. Fournier S., Lepainteur M., Kassis-Chikhani N., Huang M., Brun-Buisson C., Jarlier V. Link between carbapenemase-producing Enterobacteria carriage and cross-border exchanges: eight-year surveillance in a large French multihospitals institution. JTravel Med 2012, 19:320-323. AP-HP Outbreaks Control Group.
19. Crémet L., Bourigault C., Lepelletier D., et al. Nosocomial outbreak of carbapenem-resistant Enterobacter cloacae highlighting the interspecies transferability of the blaOXA-48 gene in the gut flora. JAntimicrob Chemother 2012, 67:1041-1043.
20. Carbonne A., Thiolet J.M., Fournier S., et al. Control of a multi-hospital outbreak of KPC-producing Klebsiella pneumoniae type 2 in France, September to October 2009. Euro Surveill 2010, 15. pii: 19734.
21. Fournier S., Brossier F., Fortineau N., et al. Long-term control of vancomycin-resistant Enterococcus faecium at the scale of a large multihospital institution: a seven-year experience. Euro Surveill 2012, 17. pii: 20229.
22. Henard S., Gendrin V., Simon L., et al. Control of a regional outbreak of vanA glycopeptide-resistant Enterococcus faecium, Eastern France, 2004-2009. Int J Hyg Environ Health 2011, 214:265-270.
23. Kluytmans-Vandenbergh M.F., Kluytmans J.A., Voss A. Dutch guideline for preventing nosocomial transmission of highly resistant microorganisms (HRMO). Infection 2005, 33:309-313.
24. Struelens M.J., Monnet D.L., Magiorakos A.P., Santos O.C.F., Giesecke J. New Delhi metallo-beta-lactamase 1-producing Enterobacteriaceae: emergence and response in Europe. Euro Surveill 2010, 15. pii: 19716.
25. Agodi A., Voulgari E., Barchitta M., et al. Containment of an outbreak of KPC-3-producing Klebsiella pneumoniae in Italy. JClin Microbiol 2011, 49:3986-3989.
26. Al-Mohri H.A., Tadros M.A., Louie L., Vearncombe M., Simor A.E. Utility of direct, real-time PCR in the management of a nosocomial outbreak of vancomycin-resistant Enterococcus faecium (vanB genotype). Eur J Clin Microbiol Infect Dis 2008, 27:321-322.
27. Aumeran C., Baud O., Lesens O., Delmas J., Souweine B., Traore O. Successful control of a hospital-wide vancomycin-resistant Enterococcus faecium outbreak in France. Eur J Clin Microbiol Infect Dis 2008, 27:1061-1064.
28. Babouee B., Widmer A.F., Dubuis O., et al. Emergence of four cases of KPC-2 and KPC-3-carrying Klebsiella pneumoniae introduced to Switzerland, 2009-10. Euro Surveill 2011, 16. pii: 19817.
29. Ben-David D., Maor Y., Keller N., et al. Potential role of active surveillance in the control of a hospital-wide outbreak of carbapenem-resistant Klebsiella pneumoniae infection. Infect Control Hosp Epidemiol 2010, 31:620-626.
30. Birgy A., Doit C., Mariani-Kurkdjian P., et al. Early detection of colonization by VIM-1-producing Klebsiella pneumoniae and NDM-1-producing Escherichia coli in two children returning to France. JClin Microbiol 2011, 49:3085-3087.
31. Borgmann S., Schulte B., Wolz C., et al. Discrimination between epidemic and non-epidemic glycopeptide-resistant E.faecium in a post-outbreak situation. JHosp Infect 2007, 67:49-55.
32. Borocz K., Szilagyi E., Kurcz A., Libisch B., Glatz K., Gacs M. First vancomycin-resistant Enterococcus faecium outbreak reported in Hungary. Euro Surveill 2005, 10:E050127.1.
33. Brossier F., Lefrancois S., Paute J., et al. Decolonisation for early control of an outbreak of vancomycin-resistant Enterococcus faecium in a geriatric rehabilitation care facility. JHosp Infect 2010, 76:368-369.
34. Centers for Disease Control and Prevention Carbapenem-resistant Klebsiella pneumoniae associated with a long-term care facility - West Virginia, 2009-2011. Morb Mortal Wkly Rep 2011, 60:1418-1420.
35. Chen S., Hu F., Liu Y., Zhu D., Wang H., Zhang Y. Detection and spread of carbapenem-resistant Citrobacter freundii in a teaching hospital in China. Am J Infect Control 2011, 39:e55-60.
36. Chlebicki M.P., Ling M.L., Koh T.H., et al. First outbreak of colonization and infection with vancomycin-resistant Enterococcus faecium in a tertiary care hospital in Singapore. Infect Control Hosp Epidemiol 2006, 27:991-993.
37. Ciobotaro P., Oved M., Nadir E., Bardenstein R., Zimhony O. An effective intervention to limit the spread of an epidemic carbapenem-resistant Klebsiella pneumoniae strain in an acute care setting: from theory to practice. Am J Infect Control 2011, 39:671-677.
38. Cohen M.J., Block C., Levin P.D., et al. Institutional control measures to curtail the epidemic spread of carbapenem-resistant Klebsiella pneumoniae: a 4-year perspective. Infect Control Hosp Epidemiol 2011, 32:673-678.
39. Comert F.B., Kulah C., Aktas E., Ozlu N., Celebi G. First isolation of vancomycin-resistant enteroccoci and spread of a single clone in a university hospital in northwestern Turkey. Eur J Clin Microbiol Infect Dis 2007, 26:57-61.
40. Dekeyser S., Beclin E., Nguyen S., Dufossez F., Descamps D. [Outbreak of vancomycin-resistant Enterococcus faecium (Van B) at the Bethune Hospital (France). Two point-prevalence surveys: May 2008 and January 2009.]. Pathol Biol (Paris) 2010, 58:e21-e25.
41. Deplano A., Denis O., Nonhoff C., et al. Outbreak of hospital-adapted clonal complex-17 vancomycin-resistant Enterococcus faecium strain in a haematology unit: role of rapid typing for early control. JAntimicrob Chemother 2007, 60:849-854.
42. Diguio N., Chanet P., Hautemaniere A., Cao-Huu T., Hartemann P., Kessler M. [Control measures for a VRE outbreak in a haemodialysis unit.]. Nephrol Ther 2009, 5(Suppl. 4):S272-S280.
43. Ergaz Z., Arad I., Bar-Oz B., et al. Elimination of vancomycin-resistant enterococci from a neonatal intensive care unit following an outbreak. JHosp Infect 2010, 74:370-376.
44. Geffen Y., Finkelstein R., Oren I., Shalaginov R., Tavleva I., Sprecher H. Changing epidemiology of carbapenem-resistant Enterobacteriaceae carriage during an outbreak of carbapenem-resistant Klebsiella pneumoniae. JHosp Infect 2010, 76:355-356.
45. Granlund M., Carlsson C., Edebro H., Emanuelsson K., Lundholm R. Nosocomial outbreak of vanB2 vancomycin-resistant Enterococcus faecium in Sweden. JHosp Infect 2006, 62:254-256.
46. Gregory C.J., Llata E., Stine N., et al. Outbreak of carbapenem-resistant Klebsiella pneumoniae in Puerto Rico associated with a novel carbapenemase variant. Infect Control Hosp Epidemiol 2010, 31:476-484.
47. Johnson P.D., Ballard S.A., Grabsch E.A., et al. Asustained hospital outbreak of vancomycin-resistant Enterococcus faecium bacteremia due to emergence of vanB E.faecium sequence type 203. JInfect Dis 2010, 202:1278-1286.
48. Kassis-Chikhani N., Saliba F., Carbonne A., et al. Extended measures for controlling an outbreak of VIM-1 producing imipenem-resistant Klebsiella pneumoniae in a liver transplant centre in France, 2003-2004. Euro Surveill 2010, 15. pii: 19713.
49. Kochar S., Sheard T., Sharma R., et al. Success of an infection control program to reduce the spread of carbapenem-resistant Klebsiella pneumoniae. Infect Control Hosp Epidemiol 2009, 30:447-452.
50. Marchaim D., Chopra T., Pogue J.M., et al. Outbreak of colistin-resistant, carbapenem-resistant Klebsiella pneumoniae in metropolitan Detroit, Michigan. Antimicrob Agents Chemother 2011, 55:593-599.
51. Mascini E.M., Troelstra A., Beitsma M., et al. Genotyping and preemptive isolation to control an outbreak of vancomycin-resistant Enterococcus faecium. Clin Infect Dis 2006, 42:739-746.
52. Matsushima A., Takakura S., Yamamoto M., et al. Regional spread and control of vancomycin-resistant Enterococcus faecium and Enterococcus faecalis in Kyoto, Japan. Eur J Clin Microbiol Infect Dis 2012, 31:1095-1100.
53. Mezzatesta M.L., Gona F., Caio C., et al. Outbreak of KPC-3-producing, and colistin-resistant, Klebsiella pneumoniae infections in two Sicilian hospitals. Clin Microbiol Infect 2011, 17:1444-1447.
54. Munoz-Price L.S., Hayden M.K., Lolans K., et al. Successful control of an outbreak of Klebsiella pneumoniae carbapenemase-producing K.pneumoniae at a long-term acute care hospital. Infect Control Hosp Epidemiol 2010, 31:341-347.
55. O'Brien D.J., Wrenn C., Roche C., et al. First isolation and outbreak of OXA-48-producing Klebsiella pneumoniae in an Irish hospital, March to June 2011. Euro Surveill 2011, 16. pii: 19921.
56. Ozorowski T., Kawalec M., Zaleska M., Konopka L., Hryniewicz W. The effect of an antibiotic policy on the control of vancomycin-resistant enterococci outbreak and on the resistance patterns of bacteria isolated from the blood of patients in a hematology unit. Pol Arch Med Wewn 2009, 119:712-718.
57. Pearman J.W. 2004 Lowbury Lecture: the Western Australian experience with vancomycin-resistant enterococci - from disaster to ongoing control. JHosp Infect 2006, 63:14-26.
58. Pereira G.H., Muller P.R., Zanella R.C., de Jesus Castro Lima M., Torchio D.S., Levin A.S. Outbreak of vancomycin-resistant enterococci in a tertiary hospital: the lack of effect of measures directed mainly by surveillance cultures and differences in response between Enterococcus faecium and Enterococcus faecalis. Am J Infect Control 2010, 38:406-409.
59. Roche C., Cotter M., O'Connell N., Crowley B. First identification of class A carbapenemase-producing Klebsiella pneumoniae in the Republic of Ireland. Euro Surveill 2009, 14. pii: 19163.
60. Sanchez-Romero I., Asensio A., Oteo J., et al. Nosocomial outbreak of VIM-1-producing Klebsiella pneumoniae isolates of multilocus sequence type 15: molecular basis, clinical risk factors, and outcome. Antimicrob Agents Chemother 2012, 56:420-427.
61. Schwaber M.J., Lev B., Israeli A., et al. Containment of a country-wide outbreak of carbapenem-resistant Klebsiella pneumoniae in Israeli hospitals via a nationally implemented intervention. Clin Infect Dis 2011, 52:848-855.
62. Servais A., Mercadal L., Brossier F., et al. Rapid curbing of a vancomycin-resistant Enterococcus faecium outbreak in a nephrology department. Clin J Am Soc Nephrol 2009, 4:1559-1564.
63. Steinmann J., Kaase M., Gatermann S., et al. Outbreak due to a Klebsiella pneumoniae strain harbouring KPC-2 and VIM-1 in a German university hospital, July 2010 to January 2011. Euro Surveill 2011, 16. pii: 19944.
64. Tuon F.F., Penteado-Filho S.R., Camilotti J., van der Heijden I.M., Costa S.F. Outbreak of vancomycin-resistant Enterococcus in a renal transplant unit. Braz J Infect Dis 2011, 15:403-405.
65. Virgincar N., Iyer S., Stacey A., et al. Klebsiella pneumoniae producing KPC carbapenemase in a district general hospital in the UK. JHosp Infect 2011, 78:293-296.
66. Wendt C., Schutt S., Dalpke A.H., et al. First outbreak of Klebsiella pneumoniae carbapenemase (KPC)-producing K.pneumoniae in Germany. Eur J Clin Microbiol Infect Dis 2010, 29:563-570.
67. Worth L.J., Thursky K.A., Seymour J.F., Slavin M.A. Vancomycin-resistant Enterococcus faecium infection in patients with hematologic malignancy: patients with acute myeloid leukemia are at high-risk. Eur J Haematol 2007, 79:226-233.
68. Wu H.S., Chen T.L., Chen I.C., et al. First identification of a patient colonized with Klebsiella pneumoniae carrying blaNDM-1 in Taiwan. JChin Med Assoc 2010, 73:596-598.
69. Xu H.T., Tian R., Chen D.K., et al. Nosocomial spread of hospital-adapted CC17 vancomycin-resistant Enterococcus faecium in a tertiary-care hospital of Beijing, China. Chin Med J (Engl) 2011, 124:498-503.
70. Yang K.S., Fong Y.T., Lee H.Y., et al. Predictors of vancomycin-resistant enterococcus (VRE) carriage in the first major VREoutbreak in Singapore. Ann Acad Med Singapore 2007, 36:379-383.
71. Yoon Y.K., Sim H.S., Kim J.Y., et al. Epidemiology and control of an outbreak of vancomycin-resistant enterococci in the intensive care units. Yonsei Med J 2009, 50:637-643.
72. Yoonchang S.W., Peck K.R., Kim O.S., et al. Efficacy of infection control strategies to reduce transmission of vancomycin-resistant enterococci in a tertiary care hospital in Korea: a 4-year follow-up study. Infect Control Hosp Epidemiol 2007, 28:493-495.
73. Bourigault C., Corvec S., Bretonnière C., et al. Investigation and management of multidrug-resistant Acinetobacter baumannii spread in a French medical intensive care unit: one outbreak may hide another. Am J Infect Control 2013, 41:652-653.
74. Magiorakos A.P., Srinivasan A., Carey R.B., et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect 2012, 18:268-281.
75. High Committee for Public Health. Safety Patient Committee (CSSP). Recommendations for the prevention of the cross-transmission of "Emerging extensively drug-resistant bacteria" (eXDR). July 2013. Available at: [accessed April 2015]. http://www.hcsp.fr.
76. French Society of Microbiology. Information letter of CA-SFM for carbapenemase-producing Enterobacteriae detection. January 2014. Available at: [accessed April 2015]. http://www.sfm-microbiologie.org/.
77. Nordmann P., Poirel L., Dortet L. Rapid detection of carbapenemase-producing Enterobacteriaceae. Emerg Infect Dis 2012, 18:1503-1507.
78. Christiansen K.J., Tibbett P.A., Beresford W., et al. Eradication of a large outbreak of a single strain of vanB vancomycin-resistant Enterococcus faecium at a major Australian teaching hospital. Infect Control Hosp Epidemiol 2004, 25:384-390.
79. Akova M., Daikos G.L., Tzouvelekis L., Carmeli Y. Interventional strategies and current clinical experience with carbapenemase-producing Gram-negative bacteria. Clin Microbiol Infect 2012, 18:439-448.
80. Ridwan B., Mascini E., Van Der Reijden N., Verhoef J., Bonten M. What action should be taken to prevent spread of vancomycin resistant enterococci in European hospitals?. BMJ 2002, 324:666-668.
81. Kurup A., Chlebicki M.P., Ling M.L., et al. Control of a hospital-wide vancomycin-resistant Enterococci outbreak. Am J Infect Control 2008, 36:206-211.
82. Centers for Disease Control and Prevention (CDC) Guidance for control of infections with carbapenem-resistant or carbapenemase-producing Enterobacteriaceae in acute care facilities. Morb Mortal Wkly Rep 2009, 58:256-260.
83. Tacconelli E., Cataldo M.A., Dancer S.J., et al. ESCMID guidelines for the management of the infection control measures to reduce transmission of multidrug-resistant Gram-negative bacteria in hospitalized patients. Clin Microbiol Infect 2014, 20(Suppl. 1):1-55.
84. European Centre for Disease Prevention and Control (ECDC) Risk assessment on the spread of carbapenemase-producing Enterobacteriaceae (CPE) through patient transfer between healthcare facilities, with special emphasis on cross-border transfer 2011, ECDC, Stockholm, Available from:, [accessed April 2015]. http://ecdc.europa.eu/en/publications/Publications/110913_Risk_assessment_resistant_CPE.pdf.
85. Glasner C., Albiger B., Buist G., et al. Carbapenemase-producing Enterobacteriaceae in Europe: a survey among national experts from 39 countries, February 2013. Euro Surveill 2013, 18(28). pii: 20525.
86. Carmeli Y., Akova M., Cornaglia G., et al. Controlling the spread of carbapenemase-producing Gram-negatives: therapeutic approach and infection control. Clin Microbiol Infect 2010, 16:102-111.
87. Müller J., Voss A., Köck R., et al. Cross-border comparison of the Dutch and German guidelines on multidrug-resistant Gram-negative microorganisms. Antimicrob Resist Infect Control 2015, 4:7.
88. Dettenkofer M., Ammon A., Astagneau P., et al. Infection control - a European research perspective for the next decade. JHosp Infect 2011, 77:7-10.